Effect of Access to Prescribed PCSK9 Inhibitors on Cardiovascular Outcomes.
Myers KD, Farboodi N, Mwamburi M, Howard W, Staszak D, Gidding S, Baum SJ, Wilemon K, Rader DJ.
Myers KD, et al. Among authors: baum sj.
Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005404. doi: 10.1161/CIRCOUTCOMES.118.005404. Epub 2019 Jul 23.
Circ Cardiovasc Qual Outcomes. 2019.
PMID: 31331194
Free PMC article.